“…Repetitive transcranial magnetic stimulation (rTMS) is a safe and noninvasive form of neural stimulation that applies focal magnetic fields to generate electric currents in the brain (Barker, Freeston, Jalinous, Merton, & Morton, ) and can increase or decrease neuronal firing depending on the intensity, frequency, and pattern of stimulation (Hoppenrath, Hartig, & Funke, ; Müller‐Dahlhaus & Vlachos, ; Tang, Thickbroom, & Rodger, ). rTMS exerts this effect on neuronal activity by modulating the activity of gamma‐aminobutyric acid (GABA)‐ and glutamate‐releasing neurons (Croarkin et al, ; Hoppenrath & Funke, ; Lenz et al, ; Lenz et al, ; Vlachos et al, ), increasing intracellular calcium levels (Grehl et al, ) and promoting the release of growth factors such as brain‐derived neurotrophic factor (BDNF) (Castillo‐Padilla & Funke, ; Makowiecki, Harvey, Sherrard, & Rodger, ; Müller, Toschi, Kresse, Post, & Keck, ; Zhang, Xing, Wang, Tao, & Cheng, )—all of which are key regulators of oligodendrogenesis and adaptive myelination (Gautier et al, ; Hamilton et al, ; Pitman & Young, ; Wong, Xiao, Kemper, Kilpatrick, & Murray, ; Xiao et al, ). For these reasons, rTMS has the potential to influence adaptive myelination, and ultimately find application in the repair of demyelinated lesions in the CNS of people with multiple sclerosis (MS).…”